Showing items 1 - 3 of 3

Your selections:

The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-Associated disease

- Liyanage, Ganesha, Trewin, Benjamin P., Buckland, Ali, Fok, Anthony, Barnett, Michael H., Reddel, Stephen W., Marignier, Romain, El Hajj, Aseel, Monif, Mastura, van der Walt, Anneke, Lechner-Scott, Jeannette, Kermode, Allan G., Lopez, Joseph A., Kalincik, T, Broadley, SA, Dale, RC, Ramanathan, S, Brilot, F, Andersen, Jane, Tea, Fiona, Merheb, Vera, Nguyen, Kristy, Lee, Fiona X. Z., Fabis-Pedrini, Marzena J., Zou, Alicia

Early life peripheral lipopolysaccharide challenge reprograms catecholaminergic neurons

- Ong, Lin Kooi, Fuller, Erin A., Sominsky, Luba, Hodgson, Deborah M., Dunkley, Peter R., Dickson, Phillip W.

Recent progress in translational research on neurovascular and neurodegenerative disorders

- Demuth, Hans-Ulrich, Dijkhuizen, Rick M., Otte, Willem M., Petzold, Gabor C., Plesnila, Nikolaus, Reiser, Georg, Reymann, Klaus G., Rueger, Maria A., Saur, Dorothee, Savitz, Sean I., Schilling, Stephan, Spratt, Neil J., Farr, Tracy D., Gelderblom, Mathias, Horsburgh, Karen, Iadecola, Costantino, Mcleod, Damian D., Michalski, Dominik, Murphy, Tim H., Orbe, Josune

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit